Autopsy report · NCT05597722
Addressing Cognitive Fog in Long-COVID-19 Patients
Cause of deathStaffing, sites or logistics
“Due to the evolving nature of COVID-related cognitive fog, it was determined that the study would be terminated at this time. The team agreed that it isn't feasible to collect enough data to evaluate the efficacy of the treatments.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 1 month before it stopped.
- 7 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Eva Szigethy
- Sponsor type
- University, hospital or other
- Conditions
- Cognitive Impairment; Long COVID
- Interventions
- Digital cognitive behavioral intervention-RxWell; Amphetamine-Dextroamphetamine
- Participants
- 7
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effects of Community-center Based Dietary Intervention on Frailty Prevention and Regression in the Elderly.
“Due to the impacts of COVID-19, the study had to terminate.” - Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
“Study terminated due to COVID-19 pandemic.” - New Formulations of Propafenone to Treat Atrial Fibrillation
“Study halted/terminated prematurely due to COVID.” - Stevia Extract and Glucose Homeostasis
“The study has been terminated due to the pandemic.” - Peripheral Nerve Stimulation for Back
“Due to COVID-19 and other factors this study was terminated early and the patients currently enrolled are being used as a small pilot study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.